NCT01364467 The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study Status COMPLETED Phase PHASE2
NCT01363297 Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT01363271 Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients Status COMPLETED Phase N/A
NCT01362673 PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions Status COMPLETED Phase PHASE1
NCT01362660 A Study to Evaluate Infants With Potential Exposure to Tanezumab Before Birth Status COMPLETED Phase N/A
NCT01360554 ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01359163 A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female Subjects Status COMPLETED Phase PHASE1
NCT01359150 A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo Status COMPLETED Phase PHASE2
NCT01358565 Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction Status COMPLETED Phase PHASE1
NCT01356628 A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer Status COMPLETED Phase PHASE2
NCT01356472 Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia Status UNKNOWN Phase PHASE4
NCT01353963 Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients Status TERMINATED Phase N/A
NCT01352845 A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. Status COMPLETED Phase PHASE3
NCT01352793 A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years Status COMPLETED Phase PHASE3
NCT01351129 Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01351025 Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells Status COMPLETED Phase PHASE2